LHM Inc. Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

LHM Inc. boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.5% during the fourth quarter, Holdings Channel reports. The fund owned 123,988 shares of the exchange traded fund’s stock after acquiring an additional 28,226 shares during the period. SPDR S&P Biotech ETF makes up approximately 3.6% of LHM Inc.’s holdings, making the stock its 5th biggest holding. LHM Inc.’s holdings in SPDR S&P Biotech ETF were worth $11,166,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC boosted its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Finally, Bank of Jackson Hole Trust bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Trading Up 2.0 %

Shares of NYSEARCA XBI opened at $87.82 on Thursday. The firm has a market capitalization of $5.79 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm’s 50-day moving average is $90.68 and its 200-day moving average is $95.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.